a
Chemistry Department, Faculty of Science, El-Minia University, 61519-El-Minia, Egypt
b
Chemistry Department, Florida Institute of Technology, Melbourne, FL 32901, U.S.A.
c
Chemistry Department, Faculty of Science, Assiut University, Assiut, Egypt
d
Applied Organic Chemistry Department, National Research Centre, Dokki, Cairo-12622, Egypt
e
Medicinal Chemistry Department, Faculty of Pharmacy, El-Minia University,
61519-El-Minia, Egypt
E-mail: ashrafaly63@yahoo.com
Abstract
The review summarizes recent literatures dealing with hydrazinecarbothioamide group in
thiocarbohydrazides and other derivatives including their physical and chemical properties along
with their applications in the synthesis of heterocycles.
Contents
Introduction
1. Synthesis of thiocarbohydrazides
1.1. Hydrazinolysis of thiophosgene
1.2. Hydrazinolysis of carbon disulfide
1.3. Hydrazinolysis of dialkyl xanthates
1.4. General procedure for the preparation of 1,5-diacyl thiocarbohydrazides
1.5. From acid hydrazides
1.6. By phase-transfer catalysis
1.7. From 1,3,4-oxadiazole-2-thione
1.8. Action of periodic acid
2. Biological activities of thiocarbohydrazide derivatives
3. Reactions of thiocarbohydrazides
3.1. Thermolysis of thiocarbohydrazides
Introduction
1. Synthesis of Thiocarbohydrazides
S
S
H 2N NH 2
+ 2NH2NH2 N N + 2HCl
Cl 1 Cl H H
Scheme 1 2
Scheme 1
Scheme 2
O O
O
aq NaOH
2 H H
2 + N N
Ar N N Ar
Ar Cl H H
Scheme 3 S 4
Scheme 3
-CH3OH 1) CS2
ArCOOCH3 + NH2.NH2 ArCONHNH2
O
2)ClCH2CO2-Na+
3) NH2NH2
H H
N N
Ar N NH2
H
S
Scheme 4 5
Scheme 4
NaOH/PEG-400
4
Ar Cl + 2
CH 2Cl 2/H 2O, r.t.
Scheme 5
Scheme 5
H
N O
N
S
OH HO
O H2NHN S
+ H H
N N
OH 6 HO N N
H H
7 8
Scheme 6 O O
Scheme 6
O O
HIO4.2H2O H H
N N
4 solvent f ree Ar N N Ar
r.t. grinding H H
3-5 min, 88-96% 9
O
Scheme 7
Scheme 7
3. Reactions of thiocarbohydrazides
N N
heat
N N N +
N HN C HN
S
Scheme 8
Scheme 8
R O R Ph R Ph
HN NH2
O NH O N
+ S
HN HN
HN R1
Ph R S NHR1 S NHR1
Ph B
10a,b A
HO
N N
S
Scheme 9 11
NHR1
Scheme 9
The structure of the compounds 11 so obtained demonstrated that the process takes place
selectively through the intermediate formation of the enamine A, which is in tautomeric
equilibrium with the hydrazone form B; at the second stage of the reaction attack by the amide
nitrogen atom on the electron-deficient carbonyl carbon atom is accompanied by closure of the
pyrazoline ring (Scheme 9).26 By contrast, 1-acetyl-2-phenylacetylene 10c reacted with
thiocarbohydrazide (2) in (i) DMSO or (ii) AcOH at room temperature only through the carbonyl
moiety to furnish N2-(Z-s-trans)- and N3-(Z-s-cis)-bis(1-methyl-3-phenyl-2-propynylidene)-
carbonothioic dihydrazides 12 in 76 or 92% yield, respectively (Scheme 10).27
H3C O S
HN NH 2
i or ii H3C N N CH3
S N N
+ -H2O H H
HN NH 2
2
Ph
(i) DMSO, rt
10c 12
(ii) AcOH, rt
Ph Ph
Scheme 10
Scheme 10
hydroxy nitriles with thiosemicarbazide, under mild conditions (rt, no catalyst, in 1:1 aqueous
ethanol, 414 h), proceeds chemo-, regio- and stereoselectively to give hitherto inaccessible tri-
functionalized (amino, hydroxylalkyl and thioamide groups) pyrazoles 15 in 5391% yields. The
hydroxyl function is easily protected by using the corresponding acetals of the starting acetylenic
hydroxynitriles (Scheme 11).28b
H3CS X
H 3CS X
C C (NH 2NH)2CS
or NH 2NHCSNH2 N
H 3CS CN N NH 2
13a,b
a; X= CN
S NHNH2
b; X= CONH2
14a; X= CN
b; X=CONH2
R2
HO
R1
R1
NC R2 + NH2CSNHNH2
N
OH
N NH2
15
S NHNH2
Scheme 11
Scheme 11
Ph Ph
O
Ph
+ 2
N CSNHNH2
Ph O Ph
BF4- N
Ph 16
Scheme 12
Scheme 12
thiocarbohydrazide (21), respectively (Scheme 13). Compound 17 reacted with CS2 in KOH to
give 4-(4,5-dihydro-5-thioxo-1,3,4-thiadiazol-2-yl)-3-methyl-1-phenyl-2-pyrazolin-5-one
(22, Scheme 13).31
N N
N O N O
21 20
Ph Ph
O
PhCHO
PhNCS NaNO2
N N N
EtOH AcOH
N O N O N O
18 17
19
Ph Ph Ph
N NH CS2/ KOH
H3C EtOH
S S
N
N O
22 Ph
Scheme 13
Scheme 13
2 + 2 RC6H4NCS RC6H4NHCSNHNH
CS
RC6H4NHCSNHNH
23
K3[Fe(CN)]6
S S
N N C N N
N 24 SR N
H
Scheme 14
Me
S
Me
N NHSO2 C
N NNH C NH2
Ph 25
Scheme 15
Br
+ 2 S
NHNH2 S
HO H2NHN
O O OH
28 N
HO N
NH2
O O H2N
O
O
H2N
S N NH2
N
OH
H
N
N S
S N
N
HO
NHNH2
S N NH2 N
O NH2
29
O
HO Scheme 16
Scheme 16
O
H H N NH
N N
aq alkali
Ar N NH 2
H Ar S
N
5 S
30
NH2
Scheme 17
R R
NRNH2 N N N N
HC(OEt)3 +
S Xylene,
S
NHR1 N S N
R = Me; R1= Ph
Scheme 18 31 R 32 R1
1
Scheme 18
NHNHCOCH3 HN N
N2H 4. H2O
S
NH2 S N CH3
33 NH 2
NHNH2 HN N
N 2H4. H2O
2eq. S
2 S N NHNH 2
NHNH2
34
Scheme 19 NH2
Scheme 19
NHNH2 PhNC HN N
S
NHMe
S N 35
Me
NHNH2
PhNC N N HN N
S
NHPh +
PhHN S S N
Scheme 20 36 37
Ph
Scheme 20
NHNH2 HN N
EtOC(Ph)=NH.HCl
S
NHPh PH 7
S N Ph
Scheme 21 38
Ph
Scheme 21
HN N
2eq. PhN=C=NPh
2
+ PhNH 2
S N NHPh
HN
NHPh
39
NPh
NHNHPh 1eq. PhN=C=NPh HN N
S + PhNH2
NHNH2
S N NHPh
Scheme 22 40
NHPh
Scheme 22
NHNHCO 2Et - OH
HN N
S
NHCO 2Et
S 41 N OH
Scheme 23 H
Scheme 23
R1
R1
NN=CR2R3 N N
HCl
S
NHCOR EtOH, , 1h
S N R
42: R= 2,6-F2C6H3; R1=Ph; R2,R3= Me H
43
S h 24
Scheme 24
HN NCS.NHNH2 N N
NH2.NH.CS.NH.NH 2
RCONCS S N R HS N R
H
R'CONCS
RCO.NH.CSNHNH.CS.NH.NH 2 RCONHCSNHNHCSNHNHCSNHCOR'
44 45
S h 25
Scheme 25
4-Methylthiophenyl acetonitrile (46) was converted into 4-methylthiophenyl acetic acid (47)
by alkaline hydrolysis (Scheme 26).43 The acid 47 was fused with thiocarbohydrazide (2) to get
4-amino-5-(4-methylthio)benzyl)-4H-1,2,4-triazole-3-thiol (48) as illustrated in Scheme 26.44 In
this procedure, an equimolar mixture of 47 and 2 was heated in an oil bath till the contents
melted. The reaction mixture was maintained at this temperature for 3 h. Then it was allowed to
cool and treated with dilute sodium bicarbonate solution in order to remove any unreacted acid.
The solid was filtered, washed with water, dried and recrystallized from ethanol to obtain the
pure triazole.44
SH
NC HOOC
N
N NH2
N
1. KOH. EtOH 2
2. HCl
fusion
48
SCH3 SCH3
46 47
H3CS
Scheme 26
Scheme 26
RCO2H 2, C
H
49 3 ON
a, C
HO
3 H
, re H
f lu N
x N
S
at N
2, he R
RCO 2R1
NH 2
50
Scheme 27
Scheme 27
R
X
+ (NH2NH)2CS
R
2
N N
HO O X
51
51; X= O, NH, SH
R= 2-Cl, 4-Cl, 3-CH3, 2,4-Cl2, 4-Cl, 3-F N
52
Scheme 28 NH2
Scheme 28
HS N CH2 N SH
n
54
NH2 NH2
Scheme 29
As an extension to the former work, fusing 2,3,5-trichlorobenzoic acid (55) with 2 afforded
the corresponding 3-(2,3,5-trichlorophenyl)-4-amino-1,2,4-triazole-5-thione (56, Scheme 30).48
Synthesized triazolethiols were screened for their antimicrobial and anti-inflammatory activities
such as against Escherichia coli (ATTC-25922), Staphylococcus aureus (ATTC-25923),
Pseudomonas aeruginosa (ATCC-27853) and Klebsiella pneumoniae. Some of the compounds
exhibited promising antimicrobial and anti-inflammatory activities.48
Cl Cl
OH f usion N N
+ (NH2NH)2CS
2 N SH
O
56 NH 2
Cl Cl Cl Cl
55 Scheme 30
Scheme 30
Me
f usion
COOH + 2
MeO
57
CH 3 CH3
N N
NH N
N N
MeO MeO H2N
H2N
S SH
58
Scheme 31
R1
O R4 S
H
R2 S N (CH)n H 2N C NH2
+
N N
O COOH H H
R3 59 2
f usion
oil bath, 180 oC
R1
O R4 N NH
R1 H
O R4 N N R2 S N (CH)n
H N S
R2 S N (CH)n O
N SH R3 NH2
O
R3 NH2 60
Scheme 32
O O
N COOH N COOH
H H
61 63
Cl (NH2NH) 2CS Cl
f usion 2 f usion
O N N
O N N N NH
NH N SH
NH2 NH N SH N S
Cl
NH2 N NH
Cl
O N N
NH N SH
NH2
Cl
62 Cl
Scheme 33 64
Scheme 33
Fusion of 2 with 2-chlorohippuric acid (61) afforded the corresponding triazole derivative
62. In the reaction of 2 with 4-chlorohippuric acid (63), double cyclization occurred to give the
triazolotriazine (64) via the expected triazole derivative (Scheme 33),50 while fusion of bis-
phenoxyacetic acids 65 with thiocarbohydrazide (2) afforded 1,4-bis-[4-amino-5-mercapto-1,2,4-
triazol-3-ylmethoxy]-phenylenes 66 in good yields (Scheme 34).51
R R
2 eq. ClCH2CO2H
OH OH HO2CH2CO OCH2CO2H
NaOH, H2O, heat
65
H2N
R' R'
R 2, heat S
N H
N
O O N
N
N R'
N NH2
66
Scheme 34
SH
Scheme 34
microwave irradiation (MW) compounds 69 and 70 were obtained with improved yields (88%)
and shorter reaction times (5-6 min; Scheme 35).52
HS
N
OH
R2 N
N
R1 H 2N
O
Method A: pyridine, ref lux 4 h HC OH
HO + 2
Method B: MW, pyridine HO CH
OH
67,68 O
R2 C R1
69,70 HC OH
Scheme 35
CH2OH
Scheme 35
COOH
S
N N OH NH2
H C OH Pyridine
+ NH2NH C NHNH2
N
HO C H 2 HS SH
N
COOH OH N
NH2 N
71 72
Scheme 36
Scheme 36
Ph O
HN NH2
AcOH S H
N
+ S 20-23oC Ph CHR
N
HN N CHR N N
73 O .HBr
Br 74
Scheme 37
Solvents affect the cyclized products resulting from the reaction of thiocarbohydrazide (2)
with carbon disulfide. In pyridine, reaction of 2 with carbon disulfide afforded the salts 75 and
76.56 In DMF, compound 2 reacted with carbon disulfide and KOH to afford the salt 77 which
can be cyclized on warming to give the corresponding 1,3,4-thiadiazoline-2-thione (Scheme
38).56
CS2 N N
2 N N N
2 +
-S 2
S-
N N N
N -
S N
H+ S
NH2 75 76 H+
NH2
CS2 S N
2
S
KOH/ DMF HN
H2N NHNHCSS-K +
Scheme 38 77
S
Scheme 38
SH
H H Cl
Ar N N Ar
CHCl 3
N N + NPh
H
4 78 -HCl
O O Cl
HN N HN N
NH NH .HCl
O O
O dil NH4OH O
Ar S N Ar S N
Ar Ar
PhN PhN
80 79
CH3COOH:(CH 3CO)2O
1:1 79-81 Ar
HN N COCH 3 a styryl
b o-hydroxy phenyl
N c methyl
O d n-propyl
O
Ar S N e p-hydroxy phenyl
Scheme 39 81 Ar
PhN
Scheme 39
S S
CHCl3
H2N NH2 + RCHO N N
N N 1:2 RHC N N CHR
H H -H2O H H
2
S NPh
SH Cl NPh S
Cl
N N CHCl3 N N
+ N N
RHC N N CHR S RHC CHR
H -HCl H
Cl
82 83
-HCl
S
S
NPh
S
N S
N NH 4OH
N NPh
RHC
84 N N N
CHR
N HCl
RHC
Scheme 40 N CHR
Scheme 40
R1 EtOH/KOH R1
+ 2
R2 N O N N N
H R2 H
R3 85 86
R3
Scheme 41
88 R Yield of 88 (%)
COR a C6H5- 80
HN b 4-HO-C6H 4- 83
NH c 4-CH3O-C6H4- 86
d 4-Br-C6H 4-CH2- 72
e Ph
H2N S CH3 62
N
PhOC COPh CH 3CN, ref lux
+ RCOHN O
COR 87 1- 2 d N S
88a-e Ph
HN
NH
Ph - H2O
Ph
HN SH O- Ph
NH O OH
HN H
RCONH .. O + N
N S RCONH O
H N S RCOHN O
Ph N S
H Ph
Scheme 42 Ph
Scheme 42
CH3
N SH
N N
O
Ar N
2 + Ar NH2
89 O O 90
Scheme43 H
Scheme 43
NNH 2
HN NNH 2
Scheme 44 RN N S
H
92
Scheme 44
O
O
NH2
OH N
R O + 2
O N
O EtOH + H 2O, N SH
94a-f
93a-f
Scheme 45
O O
R1 N N R2 R1 N N R2
2/ EtOH
-H2S, -NH3
S NH N N
N
95a, R1 = Cl, R2= Cl 96a, R1= Cl, R2= Cl NHNH2
95b, R1 = Br, R2= Cl 96b, R1= Br, R2= Cl
Scheme 46
H
NHNH2 Br N
R S CO2Et O
N
EtOH/ pyridine
2 +
N CO2 Et H
R Br
N H 2NHN S
N
X H DBM, 97 COOC2H5
99
100
N
X O
98
Scheme 47
CO 2Me
MeO2C
C O N
2 N
CH-Br
23% MeO2C
CH 2 S NHNH 2.HBr
102
CO 2Me
101
Scheme 48
HN NH
HN NH O
109
R H
108
HN NH
2 + p-Cl-C6H4-CHO
HN NH
HN NH 103 S R= p -Cl-C6H4
HN NH O
106
S 104 O
107
HN NH
HN NH
Scheme 49 105
Scheme 49
NHNHCSNHNH 2
O
S
N
111 H
HN
NH
2 O
HN
NH
2
O O
N N
H 110 H
112
Scheme 50
Scheme 50
O
+ (NH 2NH)2CS
2
HN NH
CHO
113
HN NH
Scheme 51 114
S
Scheme 51
Mohan reported on another tetrazinethione 114 from the reaction of furfural (113) with 2,
which was identified as 6-(2-furyl)-1,4,5,6-tetrahydro-s-tetrazine-3(2H)-thione (Scheme 51).72 3-
Methylspiro[indane-1,3'-hexahydro-s-tetrazine]-6'-thione (116) was obtained from the reaction
of 3-methylindan-1-one (115) with 2.73 1,7,7-Trimethyl-bicyclo[2.2.1]-heptan-2-one (117)
reacted with 2 in 2N acetic acid to give 1,7,7-trimethyl-spiro[bicycle-[2.2.1]heptane-2,3'-
[1,2,4,5]tetrazinane]-6'-thione (118).74 Treatment of 118 with ethyl chloroacetate and aldehydes
in the presence of pyridine afforded 7-arylidenespiro-[bicycle-heptane-2'-3(4H)-[2H]-
thiazolo[3,2-b]-s-tetrazin]-6-(7H)-ones 119 (Scheme 52).74 1,4-Dioxo-3,4-dihydro-
2(1H)phthalazinecarbothiohydrazide (121) was initially synthesized by reaction of phthalic
anhydride (120) with thiocarbohydrazide (2). Heterocycles 122-126, i.e. 4-substituted-1-thioxo-
1,2-dihydro[1,2,4,5]tetrazino[1,2-b]-phthalazine-6,11-diones, were subsequently synthesized by
cyclocondensation of 121 with trimethyl orthoformate, trimethyl orthoacetate, benzoic
anhydride, cyanogen bromide and carbon disulfide, respectively (Scheme 53).75
Me Me
O HN NH
115
HN NH
116 S
HN
2N acetic acid NH
+ (NH2NH) 2CS
N
HN NH N
117 O O
HN NH
S
118 119
Scheme52 S
CHAr
Scheme 52
O
S
O + NH 2NHCNHNH2
2
O S 120 O S
O
N NH N NH
N N N NH
CH O S
(O OH
O CH /K O 126 S
122 3 )3 CS 2
N NH
)
H3 3 BrC
OC NH NH2
C( N
CH 3
O S O S
O
121
N NH N NH
(PhCO)2O
N N N N
O CH 3 O S O NH 2
123 125
N NH
N N
Scheme 53
124
O Ph
Scheme 53
Ar N
NH
4 1. I2/EtOH, r t, overnight H
O N Ar
2. NH4OH S N
Scheme 54 127
O
Scheme 54
S H COCH 3
N
N H H Method B
Method A 1 N N
1 R NH2 + MeO 2C CO2Me
N CO 2Me
R
S 128 S H
N
NH
O 129a-c Method A Method B
1 N
AcOH, ref lux DMF, MW R CO 2Me
10-18 h 5-10 min
129,130 R1 Time (h) Yield of 129 (%) Time (min) Yield of 130 (%)
O 130a -c
a C6H 5- 14 56 5 75
b C6H 5-CH2- 10 60 7 87
c CH 2=CH-CH2- 18 54 10 70
Scheme 55
However, the reaction of the starting materials under microwave irradiation afforded the
same products in higher yields within a few minutes.76 Spectroscopic data excluded the
formation of the regio-isomeric heterocycle 132 (Scheme 56).
H S H
S N N
N N
Method A H H 1
1 N N
1
R N COPh NH2 + PhCO COPh R N Ph
R
or Method B 87
131a-c S PhCO
Ph 132a-c
Method A Method B
DMF, ref lux DMF, MW
24-48 h 10-20 min
131, 132 R1 Time (h) Yield of 131 (%) Time (min) Yield of 132 (%)
a C6H5- 36 82 10 98
b C6H5-CH2- 24 72 12 82
c CH2=CH-CH2- 48 76 20 92
Scheme 56
NHPhCO Me Ar
.. 2
N NHPh NHPh
HN S N
AcOH Ph
134a-e Ph N S S
10-16 h Ph N CO2Me H
Ar Ar N CO2Me
128
133 CO2Me CO2Me
CO2Me
136
135
Ph
NPh H N H
Ph N Ph N
- H2
134a-e S S
N N
Ar Ar
CO2Me H CH2O2Me
MeO2C
MeO2C
137
S
H
CHO N
N
R N NH
N O CH3COONH4 R N
N
+ 2 N
CH3COOH
138
R N O
R N O 139
Scheme 58
Ph RH R
R H
H H AcOH H N N Ph Ph
N N CH + N HN N
Ph N O Ph Ph Ph
S
S 140 H+ O Ph HS O Ph
141a-e
141,142 R Yield of 127 (%) - H2S
4-H3CO-C6H4 76
4-HO-C6H4 72 R
4-Cl-C6H4 64
2-Thienyl 60 N N Ph
Phenyl 70 Ph
Scheme 59 O Ph
142a-e
Scheme 59
MeOH, reflux
H Et3N, 6 h, ref lux (80%)
H 2N N NH 2
NH2 H NH 2 H
2 S N
S S N
N N
N + N
N Ph N
Ph
MeOH, ref lux OH H
Ph Ph
2d 143 (40%) 144 (30%)
H H
N N
H NHR1 NHR1
2 Ph NH 2 H
O S N S N
S N N
N + N
Ph N Ph N
Ph Ph MeOH, ref lux OH H
140 Ph Ph
12-24 h 145 146
Ph
H
N N
Ph NH2 H
S N Ph
S N
Ph NR1 147
MeOH, ref lux
Ph
Scheme 60
Scheme 60
OCH 3 OCH3
S
2
NH 2NHCNHNH2
H 2N
HO
N
OCH3 OCH3
HS
O 148 N
N 149
O
Br
150 O
H3CO
OCH3
N
O N
N
151 N
Scheme 61 S
Scheme 61
3-(3,5-Dimethoxyphenyl)-6-(3,4-methylenedioxyphenyl)-7H-[1,2,4]triazolo-[3,4-b][1,3,4]-
thiadiazines 151 and 6-(3,4-methylenedioxyphenyl)-7,8-dihydro-3-(3,4,5-trimethoxyphenyl)-
[1,2,4]triazolo-[4,3-b]-[1,3,4]triazines 155 were discovered as activators of caspases and
inducers of apoptosis so they may be used to induce cell death in a variety of clinical conditions
in which uncontrolled growth and spread of abnormal cells occurs; accordingly, they may be
used as therapeutic anti-cancer agents.82
OCH3
N N
OCH3 H3CO
S
NH2
NH2NHCNH2 S
HO
OCH3 H2SO4 H3CO
NH2NH2
O
O N N
O H3CO
150 NH2
N
Br
H3CO
NH2
H3CO 154
OCH3
H3CO
OCH3
N
O
N
N
155 N
N
Scheme 62 H
Scheme 62
4.15.4. Synthesis of fused 1,3,4-thiadiazines. Bromo rhodanine (156) when treated with
thiocarbohydrazide (2) yielded 5H-2-hydrazino-6-thioxo-(1,3)-thiazolo[4,5-e]-1,3,4-thiadiazine
(157) which was then condensed with aromatic aldehydes to obtain the Schiff bases 158.
Similarly, 156 was reacted with thiosemicarbazide to yield 5H-2-amino-6-thioxo-1,3-
thiazolo[4,5-e]-1,3,4-thiadiazine (159). Schiff bases of 159 were also obtained by treating it with
aromatic aldehydes (Scheme 63).83
Br
SH SH
2 S
NH2NHC=NHNH2 NH 2C=NNH2
(i) O O (i)
N
H
H 156 H
S NHNH 2 S NH2
S S
N N
S N N S N N
H H 159
157
H H
S NHN CH-Ar S N CH-Ar
S S
N N
S N N S N N
H H
158 160
Scheme 63 (i) DMF/Pyridine/MWI
Scheme 63
H3C Br
H3C S NNH2
SH
N NH2NHC=NHNH2
O (i) N NH
N 2
H N N
H 162
161
(i) Ar-CHO
H3C S NN=CH-Ar
(i) DMF/Pyridine/MWI
N NH
Scheme 64 N N
H 163
Scheme 64
ratio of 1:2 in the same solvent formed, after standing for 48 hours at room temperature,
substituted imidazothiadiazolediones 165 as minor products (21-24%) and substituted benzo-
bisimidazothiadiazoles 166 as major products (48-54%) (Scheme 65).84
Other work was also undertaken to examine the reactions of thiocarbohydrazides derived
from ethylene diamine p-CHL. Thus, two equivalents of thioureidoethylthiourea derivatives
reacted with 164 in THF at room temperature to afford substituted imino-[1,3,6]-thiadiazepane-
2-thiones 167 as minor products (14-19%) and trichloro-7-oxo-quinoxaline-1- carbothioamides
168 as major products (41-49%), in addition to the corresponding dihydrobenzoquinone (Scheme
65).85
O O H
S N R
N
Cl Cl Cl N
HN C NH2 S +
+
HN C NHR N
Cl Cl Cl
S 165
164 O O
Cl NH R
R HN N N
N N
S
S
N N
166
Cl N
RN
Cl N
NHCSNHR NH CSNHR
S
164 +
+
Cl Cl
S N
NHCSNHR H
O 168
167
Scheme 65
Scheme 65
Scheme 66 171
Scheme 66
S
O
S N NH C NHR
H
CN N
HN C NH2
+ S
HN C NHR CN
S 172 O CN
NC
S O
173
N
NH C NHR
N S
N
N
S NH C NHR
+
174 CN CN
O 175
Scheme 67 O
Scheme 67
HN N
Ar C N N S 177,178 Ar
H Ar
a C6H5
b p -C6H4-CH3
N N c p -C6H4-OCH3
d p -C6H4-Cl
Ar C N N S
H H Ar
177
NC CN
+ R NH C NH NH2
H NC CN S
Ar HC N N 176
N
N
178 S
Scheme 68 NC CN Ar
Scheme 66
NC CN CN
RNHCSNHNH 2 + H2N
CN
CN NC 176 CN
H2N N CN
H N
CN
RN N RN
N
CN
N S
CN CN 179
N
S CN
RN
S N CN
O CN N
180
181 H 2N 182
S CN
Scheme 69 RHN
Scheme 69
O O
Y X Z
RCONHNHCSNH2 +
Y X Z
O 169; Z = Cl O
164; X = Y = Cl 184; Z = CN 169 and 184
183; X = CN, Y = Cl 164 and 183
R
R O
O O
R
N N
NH2 N
N N Cl
N
N O
185
CN
O O
N
Cl
Cl S Cl Cl
OH 186
O
Cl 187 R O
N
Cl S Cl
NNHCOR
188 N
O O O
H H S N
ROCHN N N N N NHCOR
N
S S NH2 O
189
190
CN
191
Scheme 70
OH
Scheme 70
Scheme 71
CO2Et
CO2Et CO2Et
R CO2Et CO 2Et R CO 2Et
196 R OH R
COR NH ..
NH O2
HN NH N N
N N .. N N N
SH - EtOH
H N S O -H2O N N
H S O N S O S O
197a-e 199a-e 200a-e
198a-e
time
R O (h)
2 200 R Yield of 200 (%)
COR NH 2
N C6H5- 30 70
HN N a
N S b 4-HO-C6H4- 26 75
H N S CO2Et c 4-CH3O-C6H4- 24 80
d 4-Br-C6H4-CH2- 36 62
201a-e e CH 3- 48 56
Ultimately, it was proposed that aerial oxidation of 199 gives the stable heterocyclic
compounds 200 (Scheme 72).89
H2N
O
N
NH
N N
202 172 + R N CH NH NH2
N NH
a, R = NH2
N b, R = C6H5-CH=N
N
203
Ph
Scheme 73
Scheme 73
R O
NH N CHR S N Cl
H 183 N
N S + N
N
S NH Cl
169 204 NHPh H2N 205 O
S
PhHN O O NHPh
N
+ N
N
N
R O 206 207 O Scheme 74
R
Scheme 74
S NC CN
+
NH
NC 176 CN
NH N CHAr
CHAr Ar
N
PhN N
PhN N
N N
+ + S
CN S HN
S CN
210
208 HN 209 NPh
NH2
Scheme 75 NH2
Scheme 75
in ethyl acetate formed, on warming to reflux temperature for 1418 h, major (212, 213 in 54
61%) and minor (214, 215 in 2226%) products in each case (Scheme 76).92
S NC CO2Et
+
NH
NH N CHAr EtO2C CN
211
CO2Et R
O CO2Et
O
EtO2C O
NC NC +
Ar + N CSNHPh N
PhHN N
N N PhHNSC N Ar
Ar 214
212 213
S R
EtO2C O
N
Ar N CSNHPh
215
Scheme 76
Ar NC CN
NC CN N S Ar
anhy. EtOAc N S
+
Ph N NHPh r.t. 2-6 h Ph
NC CN H Ph N N
176
216 Ar Yield (%)
216a-d
a 4-OCH3-C6H4- 85
b 4-CH3-C6H4- 80
c 4-Cl-C6H4- 75
Scheme 77 d 4-NO2-C6H4- 68
Scheme 77
Aly has also demonstrated a very convenient synthesis of the fused thiazoles 217 (Scheme
78) from the reaction of aroylphenylthioureas (as analogues of thiocarbohydrazides) with -
acceptor quinones (CHL-p, DDQ and DCHNQ).94
O O 217
O Ar X Yield (%)
Ph
HN Cl X X a 70
N Cl
b Cl 65
HN S + N c Cl 60
Cl X S Ph d CN 68
X
Ar O e CN 65
O f
O CN 63
217a-i g -CH=CH-CH=CH- 78
h -CH=CH-CH=CH- 74
Scheme 78. Synthesis of f used 1,3-thiazoles i -CH=CH-CH=CH- 70
A series of complexes 218 of the type [M(TML)X2]; where TML is Tetradentate Macrocyclic
Ligand; M = Co(II), Ni(II), Cu(II), Zn(II)or Cd(II); X = Cl, CH3COO or NO2 have been
synthesized by template condensation of glyoxal and compound 2 in the presence of divalent
metal salts in methanolic medium (Scheme 79).95 The procedure can be summarized as follows:
to a stirring methanolic solution (50 mL) of 2 (10 mmol) was added a divalent cobalt, nickel,
copper, zinc or cadmium salt (5 mmol) dissolved in a minimum quantity of methanol (20 mL).
The resulting solution was refluxed for 0.5 h. After that glyoxal (10 mmol) dissolved in 20 mL
methanol was added to the refluxing mixture and refluxing continued for 610 h, depending
upon the metal salt. The mixture was concentrated to half of its volume and kept in desiccators
for 2 d. The complexes 218 were filtered, washed with methanol, acetone and ether and dried in
vacuo: yield 40%. The complexes are soluble in DMF and DMSO, but are insoluble in common
organic solvents and water.95
C
HN NH
N X
N
HC CH
MeOH M
(NH 2NH)2CS + C2H 2O2 + MX2
6-8h HC CH
2 N X N
HN NH
C
218 [M(TML)X 2]
Where M= Co(II), Ni(II), Cu(II), Zn(II) and Cd(II) S
X=Cl-, NO 3-, CH3COO -
[M(TML)X2] = Tetradentate Macrocyclic Ligand
Scheme 79
H2NHN OH NHNH2
S S
O
S Cu
N NH
O N N
[Cu(OH)2] + 2 NH 2NHCNHNH2 + H3C + 3H2O
2
CH3
H 3C CH3
219
H 2NHN NHNH
S OH S 2
O
S Cu
N NH
O N OH N 2H 2O
[Cu(OH)2] + 2NH2NHCNHNH2 + H 3C +
2
CH3
H3C CH3
Scheme 80 220
Scheme 80
Moreover, a series of complexes of the type [M(TML)X2]; 221 where TML is a tetradenate
macrocyclic ligand, M= Co(II), Ni (II), Cu (II); X= Cl-, X= CH3COO- or NO3- have been
synthesized by template condensation of benzil and thiocarbohydraide in the presence of divalent
metal salts in methanolic medium (Scheme 81).96
S
S
NH
HN HN NH
NH 2 NH2 X
2 N
O O N
Ph C C Ph Ph C C Ph
+ MeOH
M
Ph C C Ph MX 2 C Ph
Ph C
O H 2N O N X N
H2N
NH HN NH
HN
2 221
Scheme 81 S
S
Scheme 81
NH2
n NH
O O O
+ X
NH
CH 222 a,b HC
n X = S (a), O (b)
O O O
CH HC
N N
N N
H H
X
223, X = S; n = 1(a), 2(b)
Scheme 82 224, X = O; n = 1(a), 2(b)
Scheme 82
References
1. Okawara, T.; Tateyama, Y.; Yamasaki, T.; Furukawa, M. J. Heterocycl. Chem. 1988, 25,
1071.
2. Tao, E. V. P.; Rolski, S. Org. Prep. Proc. Int. 1986, 18, 272.
3. Suni, M. M.; Nair, V. A.; Joshua, C. P. Tetrahedron 2001, 57, 2003.
4. Dobosz, M.; Pachuta-Stec, A. Acta Polon. Pharm. 1996, 53, 123.
5. Korzycka, L.; Glowka, M.; Jawicka, J. Polish J. Chem. 1998, 72, 73.
6. Chande, M. S.; Pankhi, M. A.; Ambhaikar, S. B. Indian J. Chem. 2000, 39B, 603.
7. Mikhailov, O. V.; Kazymova, M. A.; Shumilova, T. A.; Chmutova, G. A.; Solovieva, S. E.
Transition Met. Chem. 2005, 30, 299.
8. Saha, G. C.; Khayer, K.; Islam, M. R.; Chowdhury, M. S. K. Indian J. Chem. 1992, 31B,
547.
9. Slovinsky, M. (Nalco Chemical Co.) U. S. Pat. 1980, 4,269,717; Chem. Abstr. 1980, 95,
103118k.
10. Autenrieth, W.; Hefner. H. Ber. Dtsch. Chem. Ges. 1925, 58B, 2151.
11. Petri, N. Z. Naturforsch. 1961, 16B, 769.
12. Beyer, H.; Lassig, W.; Schultz, U. Chem. Ber. 1954, 87, 1401.
13. Sandstrom. J. Arkiv Kemi 1952, 4, 297.
14. Li, Z.; Liu, Z.; Liao, Q-X.; Wei, Z-B.; Long, L-S.; Jiang, Y.-B. C. R. Chim. 2008, 11, 67.
15. Varma, R. S. J. Indian Chem. Soc. 1996, 43, 558.
16. Li, Z.; Zhao, Y.; Yang, J. Phosphorus Sulfur Silicon Relat. Elem. 2007, 182, 79.
17. Brzozowski, Z. Rocz. Chem. 1970, 44, 1309.
18. Donovick, R.; Pansy, F.; Stryker, G.; Bernstein, J. J. Bacteriol. 1950, 59, 667.
19. Popat, K. H.; Purohit, D. H.; Chovatia, P. T.; Joshi, H. S. J. Indian Chem. Soc. 2005, 82,
940.
20. Genova, P.; Varadinova, T.; Matesanz, A. I.; Marinova, D.; Souza, P. Toxicol. Appl.
Pharmacol. 2004, 197, 107.
21. Blumenkopf, T. A.; Harrington, J. A.; Koble, C. S.; Bankston, D. D.; Morrison, R. W., Jr.;
Bigham, E. C.; Styles, V. L.; Spector, T. J. Med. Chem. 1992, 35, 2306.
22. Abu-Hussen, A. A. A.; Emara, A. A. A. J. Coord. Chem. 2004, 57, 973.
23. Naik, A. D.; Annigeri, S. M.; Gangadharmath, U. B.; Revankar, V. K.; Mahale, V. B. J.
Inclusion Phenom. Macrocycl. Chem. 2002, 43, 291.
24. Dimmock, J. R..; Kumar, P.; Allen, T. M.; Kao, G. Y.; Halleran, S.; Balzarini, J.; De Clercq,
E. Pharmazie 1997, 52, 182.
25. Anthoni, U.; Larsen, C.; Nielsen, P. H. Acta Chem. Scand. 1966, 20, 1714.
26. Dvorko, M. Yu.; Albanov, A. I.; Chipanina, N. N.; Sherstyannikova, L. V.; Samoilov, V. G.;
Komarova, T. N.; Glotova, T. E. Chem. Heterocycl. Compd. 2006, 42, 1421.
27. Dvorko, M. Yu.; Glotova, T. E.; Albanov, A. I.; Chipanina, N. N.; Kazheva, O. N.; Shilov,
G. V.; Dyachenko, O. A. Mendeleev Commun. 2008, 18, 48.
28. (a) Hassan, S. M.; Emam, H. A.; Abdelall, M. M. J. Chem. Res. (S) 2000, 544. (b) Trofimov,
B. A.; Malkina, A. G.; Borisova, A. P.; Nosyreva, V. V.; Shemyakina, O. A.; Kazheva, O.
N.; Shilov, G. V.; Dyachenko, O. A. Tetrahedron Lett. 2008, 49, 3104.
29. Molina, P.; Tarraga, A.; Serrano, C. Tetrahedron 1984, 40, 4901.
30. Al-Raqa, S. Y.; ElSharief, A. M. Sh.; Khalil, S. M. E.; Al-Amri, A. M. Heteroatom Chem.
2006, 17, 634.
31. Kandeel, M. M.; Abbady, M. S.; Youssef, M. S. K. Bull. Kor. Chem. Soc. 2002, 23, 41.
32. El-Emary, T. I.; Al-Muaikel, N.; Moustafa, O. S. Phosphorus Sulfur Silicon Relat. Elem.
2002, 177,195.
33. Kabashima, S.; Okawara, T.; Yamasaki, T.; Furukawa, M. Heterocycles 1990, 31, 1129.
34. (a) Mavrova, A. T.; Wesselinova, D.; Tsenov, Y. A.; Denkova, P. Eur. J. Med. Chem. 2009,
44, 63. (b) Kurzer, F.; Wilkinson, M. Chem. Rev. 1970, 70, 111. (c) Mekuskiene, G.;
Burbuliene, M. M.; Jakubkiene, V.; Udrenaite, E.; Gaidelis, P.; Vainilavicius, P. Chem.
Heterocycl. Compd. 2003, 39, 1364. (d) Al-Amin, M.; Islam, M. R. Bangladesh J.
Pharmacol. 2006, 1, 21. (e) Kaplancikli, Z. A.; Turan-Zitouni, G.; zdemir, A.; Revial, G.
Eur. J. Med. Chem. 2008, 43, 155.
35. Buccheri, F.; Cusmano, G.; Gruttadauria, M.; Noto, R.; Werber, G. J. Heterocycl. Chem.
1997, 34, 1447.
36. Saikachi, H.; Kanaoka, M. Yakugaku Zasshi. 1962, 82, 683; Chem. Abstr. 1963, 58, 4543d.
37. Treppendahl, S.; Jakobsen, P. Acta Chem. Scand. Ser. B. 1977, 31, 264.
38. Weidinger, H.; Kranz, J. Chem. Ber. 1963, 96, 1059.
60. Danish, I. A.; Prasad, K. J. R. Collect. Czech. Chem. Commun. 2005, 70, 223.
61. Aly, A. A.; Hassan, A. A.; Ibrahim, Y. R. J. Chem. Res. 2008, 699.
62. Ashok, M.; Holla, B. S. Phosphorus Sulfur Silicon Relat. Elem. 2007, 182, 981.
63. Joshua, C. P.; Rajan, V. P. Aust. J. Chem. 1976, 29, 1051.
64. Holla, B. S.; Shivananda, M. K.; Veerendra, B.; Bhat, K. S. Indian J. Chem. 2003, 42B,
2649.
65. Hartenstein, H.; Blitzke, T.; Sicker, D.; Wilde, H. J. Prakt. Chem. 1993, 335, 176.
66. Mohan, J.; Kiran; Dureja, P. Indian J. Chem. 1990, 29B, 148.
67. Mohan, J.; Kataria, S. Indian J. Chem. 1994, 33B, 196.
68. Mohan, J.; Anjaneyulu, G. S. R.; Madan, D. J. Indian Chem. Soc. 1991, 68, 252.
69. Mohan, J.; Malik, N. Indian J. Chem. 1996, 35B, 685.
70. Mohan, J.; Kataria, S. Indian J. Chem. 1998, 37B, 819.
71. (a) Badawy, M. A.; Abdel-Hady, S. A. Arch. Pharm. 1991, 324, 349. (b) Joshi, K. C.; Jain,
R; Dandia, A.; Sharma,V. J. Heterocyl. Chem.1986, 23, 97.
72. Mohan, J. Indian J. Heterocycl. Chem. 1996, 6, 73.
73. Sharma, R.; Kumar, S.; Pujari, H. K. Indian J. Chem. 1990, 29B, 440.
74. Mohan, J.; Khatter, D. Indian J. Heterocyl. Chem. 2002, 12, 169.
75. Amin, A. H.; Bakherad, M. Heterocycl. Commun. 2007, 13, 311.
76. Aly, A. A.; Hassan, A. A.; El-Sheref, E. M.; Mohamed, M. A.; Brown, A. B. J. Heterocycl.
Chem. 2008, 45, 521.
77. Aly, A. A.; El-Shaieb, K. M. J. Chem. Res. 2007, 563.
78. Alajarn, M.; Cabrera, J.; Pastor, A.; Snchez-Andrada, P.; Bautista, D. J. Org. Chem. 2006,
71, 5328.
79. Abdel-Moneim, W. R. Indian J. Heterocycl. Chem. 2004, 13, 379.
80. Aly, A. A.; Hassan, A. A.; Ameen, M. A.; Brown, A. B. Tetrahedron Lett. 2008, 49, 4060.
81. Aly, A. A.; Hassan, A. A.; Gomaa, M. A.-M.; El-Sheref, E. M. ARKIVOC 2007, (xiv), 1.
82. Cai, S. X.; Drewe, J. A.; Zhang, H.-Z.; Kasibhatla, S.; Claassen, G.; Sirisoma, N. S.;
Kemnitzer, W. E. (Cytovia, Inc., USA) WO 2008/011045 A2; Chem. Abstr. 2008, 148,
191966.
83. Dabholkar, V, V.; Gavande, R. P. Indian J. Heterocyl. Chem. 2006, 16, 101.
84. Hassan, A. A.; Mohamed, N. K.; Aly, A. A.; Mourad, A. F. E. Monatsh. Chem. 1997, 128,
61.
85. Hassan, A. A.; Mourad, A.-F. E.; El-Shaieb, K. M.; Abou-Zied, A. H. Molecules 2005, 10,
822.
86. Hassan, A. A.; Mohamed, N. K.; Shawky, A. M.; Dpp, D. ARKIVOC 2003, (i), 118.
87. Hassan, A. A.; Aly, A. A.; El-Sheref, E. M. ARKIVOC 2007, (xiv), 229.
88. Hassan, A. A.; El-Shaieb, K. M.; Shaker, R. M.; Dpp, D. Heteroatom Chem. 2005, 16, 12.
89. Aly, A. A.; Hassan, A. A.; Ibrahim, Y. R.; Abdel-Aziz, M. J. Heterocycl. Chem. 2009 (in
press).
90. Hassan, A. A.; Refaey, S. M.; Shehatta, H. S. ARKIVOC 2007, (xv), 265.
91. Gomaa, M. A.-M.; Hassan, A. A.; Shehatta, H. S. Heteroatom Chem. 2006, 17, 261.
92. Hassan, A. A.; Shehata, H. S.; Dpp, D. J. Chem. Res. 2008, 725.
93. Aly, A. A.; El-Shaieb, K. M. J. Chem. Res. 2007, 207.
94. Aly, A. A.; Ahmed, E. K.; El-Mokadam, K. M. J. Sulfur Chem. 2006, 27, 419.
95. Singh, D. P.; Kumar, R.; Tyagi, P. Transition Met. Chem. 2006, 31, 970.
96. Singh, D. P.; Kumar, R.; Malik, V.; Tyagi, P. J. Enzyme Inhibition Med. Chem. 2007, 22,
177.
97. Fedorova, O. V.; Popova, V. A. Russ. J. Gen. Chem. 1995, 65, 593.
Biographical Sketches
Ashraf Abd El-Moneim Aly Shehata (born 1963). He is a Professor of Organic Chemistry in
Chemistry Department, Faculty of Science, Organic Division, El-Minia University, 61519-El-
Minia, Egypt. He was awarded with a channel system program to complete his Ph.D. program
under the supervision of Prof Dr Henning Hopf, in the field of cyclophane chemistry for two
years at TU-Brauschweig, Germany. Awarded with a scientific grant to be a scientific visitor to
TU-Braunschweig, Germany from 28 November 1997 until 31 January 1999. He published about
70 papers in sound international journals. Awarded as a visiting Professor in Sultan of Oman.
Awarded with The States Encouragement National Prize in Organic Chemistry (2004)
from the Academy of Science and Technology, Cairo, Egypt. Awarded with DAAD scholarship
for two months from 12 August 2005 until 12 October 2005 with Prof Dr Henning Hopf. He has
been selected on the boards of referees in the following journals: Journal of Organic
Chemistry, Journals of Royal Society of Chemistry (RSC), and Arkivoc. Acknowledged by
Shoman foundation (in 2006) for his research program and his list of publications. He has joint
research with Dr Alan B. Brown, Chemistry Department, University Blvd, Melbourne, Florida,
U.S.A. He has a prospective cooperation with Prof. Dr. Shinmyozu Teruo, Department of
Applied Molecular Chemistry, Institute for Materials Chemistry and Engineering, Japan. The
research group of Professor Ashraf A Aly is working for a long time on the chemistry of
cyclophanes and he is interested in study of synthetic approaches to new cyclophanes containing
heterocyclic rings. Moreover, his research activity deals with synthesis of heterocycles which
may have prospective biological and/or pharmaceutical activities. In 10-2008, he has been
invited as a visitor Professor in Saudi Arabia, Al-Jouf University, Faculty of Science, Chemistry
Department. E-mail: ashrafaly63@yahoo.com.
Dr Alan B. Brown (born 1957) was awarded a B. A. in chemistry from Middlebury College and
a Ph.D. in organic chemistry from the University of Wisconsin - Madison. After an N.I.H.
postdoctoral fellowship at Columbia University, he joined Florida Institute of Technology in
1988. His research interests include sensor science, aromaticity, and applied NMR spectroscopy.
E-mail: abrown@fit.edu.
Dr. Talaat Ibrahim Aly El-Emary. Ph.D. Assistant Prof. of Organic Chemistry, Chemistry
Department, Faculty of Science, Assiut University, Assiut, Egypt. Awarded DAAD Grant in
Tubingen University, Institute of Organic Chemistry, Germany at 1998 for 2 months July &
August 1998. He published 37 papers in sound international journals specialized in organic
chemistry and inorganic chemistry journals. E-mail: emary768@hotmail.com.
Dr. Ashraf Metwally Mohamed Ewas was born in 1968, Beni-suef, Egypt. A researcher in
National Research Center, Chemical Industries Research Division, Applied Organic Chemistry
Department., Giza-Dokki, Egypt. His Research interests on the synthesis of heteroorganic
compounds of biological interest, specially as anticancer agents. In 1998, he was awarded many
scientific missions to Poland in order to complete his Ph.D. Program (1997-1998) under
supervision of Professor Marian Mikolajczyk. Awarded another three scientific missions
dated in 1999, 2001 and 2006 to Poland under the same program to elaborate his Post doctoral
research. He participated in the research program on the (Synthesis of enantiomerically pure
cyclopropylphosphonate derivatives via asymmetric cyclopropanation of chiral -
phosphorylvinyl sulfoxides). Awarded a post doctoral scientific grant for supporting a young
researchers (February, 2007) from the Ministry of High Education and Scientific Research in the
Faculty of Organic Chemistry, TU-Dresden, Germany. He participated in the research program
entitled (New domino reactions with sulfones) with Professor Peter Metz. In 09-2008, he has
been invited as a visitor assistant Professor in Saudi Arabia, Al-Jouf University, Faculty of
Science, Chemistry Department. E-mail: ammewas@yahoo.com.
Mohamed Ramadan Eisa (born 1978) was awarded a B. Pharm. Sci., from Faculty of
Pharmacy, Helwan University in 2000 and a M.Sc., Pharmaceutical Organic Chemistry from
Faculty of Pharmacy, El-Minia University in 2005. His research interests the design of novel
heterocycles which posses anticancer activity. He registries his Ph.D. under the supervision of
Professor Ashraf A. Aly. E-mail: elbashamohammed@yahoo.com.